Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Attorneys Michael D. Marrese and John M. Phillips of Morgan & Morgan Recover $939,276.78 Verdict for Woman Injured in Car Accident

(EMAILWIRE.COM, May 05, 2010 ) Jacksonville, FL - Morgan and Morgan trial attorneys Michael D. Marrese and John M. Phillips have recovered a $939,276.78 verdict on behalf of their client, a woman who was injured in an auto accident. As a result of these injuries, she has had to undergo extensive medical treatment and will need medication for the rest of her life.

On August 13, 2008, a 31-year-old mother of two was rear-ended at a stop light on Atlantic Boulevard in Jacksonville, Florida. The next day, she sought treatment from her primary care doctor, as well as chiropractic treatment and pain pain management care from PhysicianÂ’s Group. In April 2009, she had a two level percutaneous laser microdiscectomy performed on her lower back in Tampa, Florida. She continued to treat with PhysicianÂ’s Group for Piriformis Syndrome, a painful condition that affects her left hip. She has had between 12 to 15 pain injections in her back and hip and will require pain medications for life. A jury in Jacksonville, Duval County, Florida awarded her $939,276.78 in damages.

This case was tried by attorneys Michael D. Marrese and John M. Phillips of Morgan and Morgan.

About Morgan & Morgan

Morgan and Morgan is one of the largest Personal Injury law firms in the country with multiple office locations throughout Florida and the Southeast. The firm handles auto accident cases, personal injury cases, and medical malpractice cases, as well as claims against drug and medical device manufacturers. Visit Morgan and Morgan online at http://www.forthepeople.com for a free case evaluation and information about your legal rights.


Morgan & Morgan
Michael D. Marrese and John M. Phillips
(877) MORGAN-LAW
pressrelease@lawyercentral.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Pfizer's Ibrance drug slows progression of breast cancer
30 May 2015 at 10:17am
By Deena Beasley CHICAGO (Reuters) - A Phase III trial of Pfizer Inc's Ibrance showed that, in combination with hormone therapy, the drug more than doubled the duration of disease control for women with the most common type of breast cancer. At the time of an interim analysis, patients given Ibrance and AstraZeneca Plc's Faslodex (fulvestrant), a widely used treatment to block estrogen, lived an average of 9.2 months before their cancer worsened. The trial, presented in Chicago at a meeting of the American Society of Clinical Oncology, enrolled 521 patients whose breast cancer was classified as estrogen-receptor positive, human epidermal growth factor receptor 2-negative.

Study sees benefit from more extensive breast cancer surgery
30 May 2015 at 9:54am
CHICAGO (AP) ? Having a little extra tissue taken off during breast cancer surgery greatly lowers the risk that some cancer will be left behind and require a second operation, according to a new study that could change care for more than 100,000 women in the United States alone each year.


New treatments may prolong health after breast cancer
30 May 2015 at 8:59am

Promising advances in research could mean longer, healthier lives for women with breast cancer, the number one cancer in women worldwide, experts said Saturday at a major US cancer conference. A new targeted therapy that appears to double the amount of time cancer can be held in check, a drug that offers more women a chance at healthy lives post-diagnosis and a surgical option to remove extra tissue in order to reduce the likelihood of cancer's return were among the findings presented at the American Society of Clinical Oncology annual meeting in Chicago. The targeted drug, palbociclib, is made by Pfizer and was granted accelerated approval by the US Food and Drug Administration earlier this year for use in women with the most common form of advanced breast cancer, known as estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-).



4 Traps to Avoid When You're Filled With Anxiety
30 May 2015 at 8:57am

When we're slipping on anxiety's slopes, it's usually not pretty.We rant. We rave. We make blanket statements on the condition of our lives.When under pressure, inaccurate self-judgments are likely to creep in. We forget to factor in that we're overworked, tired or just plain depleted. We lose sight that we're resilient, and quite capable of...



Former quadriplegic runs, walks to show others they can
30 May 2015 at 8:46am

LOS ANGELES (AP) ? The worst day of Aaron Baker's life wasn't when the then-20-year-old professional motocross racer crashed his bike one spring day in 1999, flew over the handlebars and hit the ground head-first, paralyzing him from the next down.


Eisai drug extends survival in patients with rare cancers
30 May 2015 at 8:05am
A drug made by Japan's Eisai Co that was originally derived from sea sponges helped extend lives of patients with soft-tissue cancers known as sarcomas by two months, a significant advance for these rare cancers with few treatment options, Belgian researchers said on Saturday. The researchers studied the drug, known as eribulin, in 452 patients with two forms of sarcomas - leiomyosarcoma, which starts in smooth muscles, and adipocytic sarcoma, which starts in fat tissue. "For a disease where such few treatment options exist, a two month improvement in survival is significant," said Dr. Patrick Schoffski, a medical oncologist at University Hospitals Leuven in Belgium, who presented the findings at the American Society of Clinical Oncology meeting on Saturday.

J&J multiple myeloma drug offers hope after others stop working: study
30 May 2015 at 8:03am
An experimental biotech drug being developed by Johnson & Johnson may offer hope to multiple myeloma patients who have run out of options, according to data from a midstage study released at a cancer meeting on Saturday. J&J plans to use the Phase II study to seek U.S. and European approval of its antibody daratumumab to treat the blood cancer. The drug received breakthrough designation from the U.S. Food and Drug Administration, which can help speed the approval process.


New research shows immunotherapy targeting several cancers
30 May 2015 at 7:38am

Immunotherapy, which has shown remarkable success against advanced melanoma skin cancers, is now being used to target other cancers that are tough to treat. The results of several clinical trials were presented on the opening day of the American Society of Clinical Oncology's (ASCO) annual conference in Chicago on Friday. In some cases, immunotherapy has been shown to completely eradicate cancer.



U.N. warns of coming hunger in North Korea
30 May 2015 at 2:58am

By Tom Miles GENEVA (Reuters) - A drought in North Korea could lead to huge food shortages this year, the top U.N. official in the country told Reuters in an interview. Rainfall in 2014, the lowest in records going back 30 years, was 40-60 percent below 2013 levels, and reservoirs are very low, said Ghulam Isaczai, the U.N. resident coordinator.



U.S. military orders review as anthrax mishap widens
29 May 2015 at 10:31pm

By Phil Stewart WASHINGTON (Reuters) - The U.S. military said on Friday it discovered even more suspected shipments of live anthrax than previously thought, both in the United States and abroad, and ordered a sweeping review of practices meant to inactivate the bacteria. The Pentagon said a total of 11 states, two more than it first acknowledged, received "suspect samples," as did Australia and South Korea. It had previously only identified a foreign shipment to a U.S. air base south of Seoul.


Rights activists protest award for ex-Montana judge who blamed victim of rape
29 May 2015 at 8:07pm
A small group of women's rights activists rallied in Montana on Friday to protest a lifetime achievement award for a state judge censured for suggesting that a 14-year-old girl was partly to blame for her rape by a teacher. More than two dozen protesters led by the Montana chapter of the National Organization for Women attended the candlelight vigil outside the Yellowstone Art Museum in Billings where former state District Judge G. Todd Baugh was to be given the annual award by a local bar association, said Marian Bradley, regional NOW head.

Kansas hospital monitoring patient for possible Ebola infection
29 May 2015 at 5:43pm
The University of Kansas Hospital said on Friday it was monitoring a patient for a possible Ebola infection after he returned from the West African nation of Sierra Leone and developed a fever. "The patient is extremely low risk. It's just the fever that tipped the balance," Dr. Lee Norman at University of Kansas Hospital in Kansas City, Kansas, told a news conference.

Pentagon: Anthrax shipments broader than first thought
29 May 2015 at 4:07pm
WASHINGTON (AP) ? The Pentagon said Friday that the Army's mistaken shipments of live anthrax to research laboratories were more widespread than it initially reported, prompting the Defense Department's second-ranking official to order a thorough review.

U.S. military orders broad review as anthrax mishap widens
29 May 2015 at 3:39pm
WASHINGTON (Reuters) - The U.S. military said on Friday it discovered even more suspected cases of inadvertent shipments of live anthrax than previously thought, both in the United States and abroad, and ordered a sweeping review of its practices for inactivating samples. "As of now, 24 laboratories in 11 states and two foreign countries are believed to have received suspect samples," the Pentagon said in a statement. (Reporting by Phil Stewart; Editing by Sandra Maler)

Zimmerman gets GPS protection from Florida shooter
29 May 2015 at 3:29pm
A Florida man who this month fired a shot at George Zimmerman, the man acquitted of murder in the 2012 death of an unarmed black teenager, was ordered on Friday to wear a GPS tracking device to warn of possible future attacks, according to local news reports of the court hearing. Matthew Apperson, 36, was charged with aggravated assault with a deadly weapon, shooting into a vehicle and aggravated battery with a deadly weapon after an encounter with Zimmerman on a road in Lake Mary, central Florida, on May 11. In a motion asking for the GPS requirement, prosecutors said Apperson has a history of mental illness including bipolar disorder and general anxiety disorder.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC